We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Eppendorf AG with Positive First Half-year 2019

Product News   Aug 20, 2019

 
Eppendorf AG with Positive First Half-year 2019

Image credit: Eppendorf

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Scientists on Standby: Supporting Recruitment of Scientists for COVID-19 Testing

Product News

Scientists on Standby is a portal enabling scientists with relevant skills and experience to volunteer their time, expertise and support for COVID-19 screening and testing.

READ MORE

New Collaboration Aims to Increase COVID-19 Reagent Production

Product News

OXGENE™ and The Native Antigen Company have announced a collaboration to scale up their antigen manufacturing capabilities to deliver high-purity, recombinant proteins for the development of diagnostics and vaccines.

READ MORE

Neoantigen Specific Peptide Synthesis Service for Precision Immuno-oncology Therapeutic Development

Product News

The new service from GenScript aims to overcome the challenges of manufacturing difficult neoantigen peptides critical to personalized cancer vaccine and T-cell therapy generation.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE